Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BCL2 | P10415 | 14/20 | 0.51 |
| ▸ | BAK1 | Q16611 | 5/20 | 0.51 |
| ▸ | BCL2L1 | Q07817 | 11/20 | 0.49 |
| ▸ | HTR7 | P34969 | 2/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2826626 | 0.90 | BCL2 (0.60) | BCL2BAK1BCL2L1HTR7 | |
| SCHEMBL1743570 | 0.82 | BCL2 (0.56) | BCL2BAK1BCL2L1HTR7 | |
| SCHEMBL1743551 | 0.81 | HTR7 (0.63) | BCL2BAK1BCL2L1HTR7 | |
| SCHEMBL1960149 | 0.81 | BCL2 (0.58) | BCL2BAK1BCL2L1HTR7 | |
| SCHEMBL1742171 | 0.81 | BCL2 (0.56) | BCL2BAK1BCL2L1HTR7 | |
| SCHEMBL1958974 | 0.81 | BCL2 (0.58) | BCL2BAK1BCL2L1HTR7 | |
| SCHEMBL1956323 | 0.80 | BCL2 (0.55) | BCL2BAK1BCL2L1HTR7 | |
| SCHEMBL1957837 | 0.79 | BCL2 (0.57) | BCL2BAK1BCL2L1HTR7 | |
| SCHEMBL1955301 | 0.79 | BCL2 (0.62) | BCL2BAK1BCL2L1 | |
| SCHEMBL1742388 | 0.79 | BCL2 (0.65) | BCL2BCL2L1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2507229-A1 | SULFONAMIDE DERIVATIVES AS BCL-2-SELECTIVE APOPTOSIS-INDUCING AGENTS FOR THE TREATMENT OF CANCER AND IMMUNE DISEASES | Abbott Laboratories (US) | 2012-10-10 | — | — | EP | disclosed |
| EP-2376480-A2 | SULFONAMIDE DERIVATIVES AS BCL-2-SELECTIVE APOPTOSIS-INDUCING AGENTS FOR THE TREATMENT OF CANCER AND IMMUNE DISEASES | Abbott Laboratories (US) | 2011-10-19 | — | — | EP | disclosed |
| WO-2011068561-A1 | SULFONAMIDE DERIVATIVES AS BCL-2-SELECTIVE APOPTOSIS-INDUCING AGENTS FOR THE TREATMENT OF CANCER AND IMMUNE DISEASES | ABBOTT LABORATORIES (US) | 2011-06-09 | — | — | WO | disclosed |
| WO-2010065865-A2 | BCL-2-SELECTIVE APOPTOSIS-INDUCING AGENTS FOR THE TREATMENT OF CANCER AND IMMUNE DISEASES | ABBOTT LABORATORIES (US) | 2010-06-10 | — | — | WO | disclosed |